The Government Medical College and Hospital (GMCH) in the city will lead ‘Platina Trial’, which is a state-level clinical trial to assess the efficacy of plasma therapy to treat severely ill Covid-19 patients.
Officials said more than 500 patients in the state would be given blood plasma obtained from recovered patients as part of these trials.
“Medical Education Department’s proposal of the world’s largest trial for plasma therapy for severe Covid-19 patients has got DCGI nod. Will cover over 500 patients,” tweeted Dr. Sanjay Mukherjee, secretary of medical education, on Thursday.
These are being touted as the largest such trials in the world. After the Drug Controller General of India (DCGI) gave its final nod, GMCH, Nagpur, is planning to involve 238 patients from 23 hospitals across the state.
State nodal officer and administrative coordinator for trials, Dr Mohd Faizal, said his team believed plasma therapy may save the lives of at least 5,000 critical patients in the next six months.
“We are working on the concept of ‘from cured to the critical’. We believe that the therapy is effective and has shown positive results so far,” Dr. Faizal said. “Results of these trials can be the turning point of Covid-19 treatment in India. Based on our results, ICMR may revise national guidelines for plasma therapy and bring relief to people,” Dr. Faizal added.
(With inputs from timesofindia)